Effect of rEPO in FGF23 in ESRD Patients
NCT03803514
·
clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Anemia
Chronic Kidney Diseases
Interventions
DRUG:
Recombinant EPO
Sponsor
University of Chile